Healthcare -
Biotechnology - NASDAQ - US
$ 6.58
-0.303 %
$ 326 M
Market Cap
-1.31
P/E
RGNX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities RGNX - REGENXBIO Inc.
191 M
LAST VALUE
57.15%
2 YEAR CAGR
21.83%
5 YEAR CAGR
0.00%
10 YEAR CAGR